Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Journal of Biomolecular Screening
|
April 28, 2011
Open innovation for phenotypic drug discovery: The PD2 assay panel
Jonathan A Lee, Shaoyou Chu, Francis S Willard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin
Catherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
British Journal of Pharmacology
|
September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism
Venkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
Journal of Lipid Research
|
April 24, 2007
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Yue-Wei Qian, Robert J Schmidt, Youyan Zhang, et al.
The Journal of Biological Chemistry
|
February 2, 2008
AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase
Yan Qun Chen, Ming-Shang Kuo, Shuyu Li, et al.
Science Advances
|
November 3, 2021
Deletion of <i>Abi3</i> gene locus exacerbates neuropathological features of Alzheimer's disease in a mouse model of Aβ amyloidosis
Hande Karahan, Daniel C Smith, Byungwook Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 4, 2026
Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses
Angela K Haskell, Joshua A Kulas, William E Carter, et al.
Plos One
|
July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Jonathan A Lee, Paul Shinn, Susan Jaken, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
Frances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology
Frances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Journal of Biomolecular Screening
|
April 28, 2011
Open innovation for phenotypic drug discovery: The PD2 assay panel
Jonathan A Lee, Shaoyou Chu, Francis S Willard, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin
Catherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
British Journal of Pharmacology
|
September 13, 2017
Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism
Venkatesh Krishnan, Yanfei L Ma, Catherine Z Chen, et al.
Journal of Lipid Research
|
April 24, 2007
Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Yue-Wei Qian, Robert J Schmidt, Youyan Zhang, et al.
The Journal of Biological Chemistry
|
February 2, 2008
AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase
Yan Qun Chen, Ming-Shang Kuo, Shuyu Li, et al.
Science Advances
|
November 3, 2021
Deletion of <i>Abi3</i> gene locus exacerbates neuropathological features of Alzheimer's disease in a mouse model of Aβ amyloidosis
Hande Karahan, Daniel C Smith, Byungwook Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 4, 2026
Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses
Angela K Haskell, Joshua A Kulas, William E Carter, et al.
Plos One
|
July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Jonathan A Lee, Paul Shinn, Susan Jaken, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
Frances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology
Frances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Page
of 5